General
Preferred name
ASPARAGINE
Synonyms
Asparamide(-)-Asparagine ()
L-asparagine ()
L-Asparagine (monohydrate) ()
(-)-Asparagine ()
Asn ()
Asparamide ()
2-Aminosuccinamic acid, alpha-aminosuccinamic acid ()
L(+)-Asparagine monohydrate ()
Asparagine anhydrous ()
L-asparagine anhydrous ()
7ng0a2tuhq ()
NSC-82391 ()
L-Asparagine (hydrate) ()
L-Asparagine-d3 (hydrate) ()
P&D ID
PD010188
CAS
32640-57-6
5794-13-8
70-47-3
2483831-59-8
Tags
available
drug
Drug Status
approved
investigational
nutraceutical
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
29
DESCRIPTION
Asparagine is a non-essential amino acid that is involved in the metabolic control of cell functions in nerve and brain tissue. It is biosynthesized from aspartic acid and ammonia by asparagine synthetase. It is used for nutritional supplementation, also for treating dietary shortage or imbalance.
(Enamine Bioactive Compounds)
DESCRIPTION
L(+)-Asparagine monohydrate is a non-essential amino acid, participate in neurological and metabolic regulation of tissue cell function.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
18
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
Enamine Bioactive Compounds
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NPC Screening Collection
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
66
Molecular Weight
132.05
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
3
Rotatable Bonds
3
Ring Count
0
Aromatic Ring Count
0
cLogP
-1.73
TPSA
106.41
Fraction CSP3
0.5
Chiral centers
1.0
Largest ring
0.0
QED
0.42
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Endogenous Metabolite
Human Endogenous Metabolite
ASNS, ASRGL1, NARS, NARS2, SLC1A5, SLC38A3
Apoptosis
DNA/RNA Synthesis
Pathway
Metabolism
Cell Cycle/DNA Damage
Metabolic Enzyme/Protease
Source data

